The Record

The Orders Library

Name: The COVID Project Orders Library
Creator: The COVID Project

13,511 instruments indexed by The COVID Project: the orders of the fifty States and the District, forty metros, the federal layer and the agencies; the standing duties; the organizers' notices; the legal authorities. Filter by kind, State, limitation type, quarter and more; open the exhibit; download what you find.

Double quotes make a phrase ("stay at home"). An exhibit ID (TX-004) opens its record first.

The COVID Projectcovidproject.com/library

Filters:Agency cluster: Other federal health agencies Health care orders Travel and quarantine Clear all

55 instruments · showing 1–25

Sort Per page

Exhibit	Instrument	Issuer	Jurisdiction	Issued	Quarters	Limitations	Grade
Ex. AGY-FED-HEALTH-OTHER-040	Declaration Under the Public Readiness and Emergency Preparedness Act for Medical Countermeasures Against COVID-19, 85 Fed. Reg. 15198 (Mar. 17, 2020)Declaration Under the Public Readiness and Emergency Preparedness Act for Medical Countermeasures Against COVID-19	Alex M. Azar II, Secretary of Health and Human Services	United States (federal); Department of Health and Human Services, Office of the SecretaryFederal	Mar. 10, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Emergency declarationHealth care ordersOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-124	Interim Final Rule, Control of Communicable Diseases; Foreign Quarantine (requirements for airlines to collect and transmit designated passenger and crew information), 85 Fed. Reg. 7874 (Feb. 12, 2020)Control of Communicable Diseases; Foreign Quarantine	Centers for Disease Control and Prevention, HHS (Alex M. Azar II, Secretary)	United States (federal); Centers for Disease Control and Prevention, HHSFederal	Feb. 12, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Travel and quarantineWorkplace rules	Primary source read
Ex. AGY-FED-HEALTH-OTHER-125	Agency Order, Collection of Certain Data Regarding Passengers and Crew Arriving From Foreign Countries by Airlines (issued Feb. 18, 2020), 85 Fed. Reg. 10439 (Feb. 24, 2020)Collection of Certain Data Regarding Passengers and Crew Arriving From Foreign Countries by Airlines	Robert R. Redfield, M.D., Director, CDC	United States (federal); Centers for Disease Control and Prevention, HHSFederal	Feb. 18, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Travel and quarantineWorkplace rules	Primary source read
Ex. AGY-FED-HEALTH-OTHER-032	Policy for Diagnostics Testing in Laboratories Certified To Perform High Complexity Testing Under CLIA Prior to Emergency Use Authorization for Coronavirus Disease-2019 During the Public Health Emergency; Immediately in Effect Guidance, 85 Fed. Reg. 13138 (Mar. 6, 2020)Policy for Diagnostics Testing in Laboratories Certified To Perform High Complexity Testing Under the Clinical Laboratory Improvement…	Food and Drug Administration, HHS	United States (federal); Food and Drug AdministrationFederal	Feb. 29, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-052	Emergency Use Authorization: NIOSH-approved air purifying respirators for health care personnel (issued Mar. 2, 2020; reissued Mar. 28, 2020 and July 12, 2021)Letter of Authorization to CDC, NIOSH-Approved Air Purifying Respirators (reissued July 12, 2021)	Jacqueline A. O'Shaughnessy, Acting Chief Scientist, FDA (letter to CDC)	United States (federal); Food and Drug AdministrationFederal	July 12, 2021	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersSupply chain	Primary source read
Ex. AGY-FED-HEALTH-OTHER-064	VA announcement of Mar. 10, 2020: 'No Visitor' stance and suspension of new admissions at all VA nursing homes (community living centers) and spinal cord injury and disorder centersVA announces safeguards to protect nursing home and spinal cord injury patients	Department of Veterans Affairs (Secretary Robert Wilkie)	United States (federal); Department of Veterans Affairs, Veterans Health AdministrationFederal	Mar. 10, 2020	2020 Q22020 Q3	Context (guidance or announcement)Gathering capHealth care orders	Primary source read
Ex. AGY-FED-HEALTH-OTHER-072	Federal Bureau of Prisons COVID-19 Action Plan, Phase Two: agency-wide modified operations (Mar. 13, 2020)Federal Bureau of Prisons COVID-19 Action Plan: Agency-wide Modified Operations	Federal Bureau of Prisons (Director), after coordination with DOJ and the White House	United States (federal); Federal Bureau of PrisonsFederal	Mar. 13, 2020	2020 Q2	Business closureGathering capTravel and quarantineWorkplace rules	Primary source read
Ex. AGY-FED-HEALTH-OTHER-008	DEA-DC-015, Exception to 21 C.F.R. 1301.74(h) for Narcotic Treatment Programs (take-home delivery by NTP staff, law enforcement or National Guard)SAMHSA Exemption - NTP Deliveries (Coronavirus)	Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA (letter to Assistant Secretary Elinore McCance-Katz, SAMHSA)	United States (federal); Drug Enforcement Administration, Diversion Control DivisionFederal	Mar. 16, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-009	DEA-DC-016, COVID-19 Information Page: Telemedicine (designation that the section 802(54)(D) telemedicine allowance applies to all schedule II-V controlled substances in all areas of the United States)Use of Telemedicine While Providing Medication Assisted Treatment / COVID-19 Telemedicine (updated)	Drug Enforcement Administration, Diversion Control Division (with the HHS Secretary's designation of Mar. 16, 2020)	United States (federal); Drug Enforcement Administration, Diversion Control DivisionFederal	Mar. 16, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Telework mandateHealth care ordersOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-026	Opioid Treatment Program (OTP) Guidance (Mar. 16, 2020; updated Mar. 19, 2020): blanket take-home exceptionsOpioid Treatment Program (OTP) Guidance	SAMHSA (Assistant Secretary for Mental Health and Substance Use)	United States (federal); Substance Abuse and Mental Health Services AdministrationFederal	Mar. 16, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-001	Notification of Enforcement Discretion for Telehealth Remote Communications During the COVID-19 Nationwide Public Health Emergency, 85 Fed. Reg. 22024 (Apr. 21, 2020)Notification of Enforcement Discretion for Telehealth Remote Communications During the COVID-19 Nationwide Public Health Emergency	Roger T. Severino, Director, Office for Civil Rights, HHS	United States (federal); Department of Health and Human Services, Office for Civil RightsFederal	Mar. 17, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Telework mandateHealth care ordersOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-027	COVID-19 Public Health Emergency Response and 42 CFR Part 2 GuidanceCOVID-19 Public Health Emergency Response and 42 CFR Part 2 Guidance	SAMHSA	United States (federal); Substance Abuse and Mental Health Services AdministrationFederal	Mar. 19, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Context (guidance or announcement)Health care ordersOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-074	Updates to BOP COVID-19 Action Plan: Inmate Movement (Mar. 19, 2020)Updates to BOP COVID-19 Action Plan - Inmate Movement	Federal Bureau of Prisons	United States (federal); Federal Bureau of PrisonsFederal	Mar. 19, 2020	2020 Q2	Travel and quarantineQuarantine and isolation	Primary source read
Ex. AGY-FED-HEALTH-OTHER-010	DEA-DC-017 (DEA065), Dear Registrant letter on early refills and 90-day supplies of controlled substances during the COVID-19 emergencyEarly RX Refill (OMB 3-20-20)	Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA	United States (federal); Drug Enforcement Administration, Diversion Control DivisionFederal	Mar. 20, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-043	Guidance for Industry and FDA Staff: Enforcement Policy for Ventilators and Accessories and Other Respiratory Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (March 2020)Enforcement Policy for Ventilators and Accessories and Other Respiratory Devices During the Coronavirus Disease 2019 (COVID-19) Public…	Food and Drug Administration, CDRH	United States (federal); Food and Drug Administration, Center for Devices and Radiological HealthFederal	Mar. 22, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Context (guidance or announcement)Health care ordersSupply chainOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-049	Emergency Use Authorization: Imported, Non-NIOSH-Approved Disposable Filtering Facepiece Respirators (issued Mar. 24, 2020; reissued Mar. 28, 2020, May 7, 2020 and Mar. 24, 2021; revoked July 6, 2021)Letter of Authorization, Imported Non-NIOSH-Approved Disposable Filtering Facepiece Respirators (reissued Mar. 24, 2021)	Denise M. Hinton, Chief Scientist, FDA	United States (federal); Food and Drug AdministrationFederal	Mar. 24, 2021	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersSupply chain	Primary source read
Ex. AGY-FED-HEALTH-OTHER-051	Emergency Use Authorization: Ventilators, anesthesia gas machines modified for use as ventilators, positive pressure breathing devices modified for use as ventilators, ventilator tubing connectors and ventilator accessories (Mar. 24, 2020)Letter of Authorization to Manufacturers and Other Stakeholders: Ventilators	Denise M. Hinton, Chief Scientist, FDA	United States (federal); Food and Drug AdministrationFederal	Mar. 24, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersSupply chain	Primary source read
Ex. AGY-FED-HEALTH-OTHER-011	DEA-DC-018 (DEA067), Dear Registrant letter granting an exception to separate State registration for practitioners dispensing in additional States during the COVID-19 emergencyDEA State Reciprocity (final) (Signed)	Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA	United States (federal); Drug Enforcement Administration, Diversion Control DivisionFederal	Mar. 25, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Telework mandateHealth care ordersOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-013	DEA-DC-021 (DEA073), letter to practitioner registrants and pharmacists announcing temporary exceptions for oral schedule II prescriptions in emergency situations during the COVID-19 emergencyOral CII for regular CII script (Final)	Drug Enforcement Administration, Diversion Control Division	United States (federal); Drug Enforcement Administration, Diversion Control DivisionFederal	Mar. 27, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-066	VA announcement of Mar. 27, 2020 releasing the VHA COVID-19 Response Plan: elective and non-emergent procedures postponed; outpatient care shifted to telehealthVA Releases COVID-19 Response Plan	Department of Veterans Affairs	United States (federal); Department of Veterans Affairs, Veterans Health AdministrationFederal	Mar. 27, 2020	2020 Q2	Context (guidance or announcement)Telework mandateHealth care orders	Primary source read
Ex. AGY-FED-HEALTH-OTHER-050	Emergency Use Authorization: Battelle Critical Care Decontamination System for decontaminating compatible N95 respirators (issued Mar. 28, 2020; reissued Jan. 21, 2021; revoked June 30, 2021)Letter of Authorization, Battelle CCDS Critical Care Decontamination System (reissued Jan. 21, 2021)	Denise M. Hinton, Chief Scientist, FDA (letter to Battelle Memorial Institute)	United States (federal); Food and Drug AdministrationFederal	Jan. 21, 2021	2020 Q22020 Q32020 Q42021 Q12021 Q2	Health care ordersSupply chain	Primary source read
Ex. AGY-FED-HEALTH-OTHER-058	IHS Coronavirus (COVID-19) News page listing the Tribal and Urban Indian Organization Leader letters of Mar. 9, 16, 23 and 27, 2020 (archived Mar. 29, 2020)Coronavirus (COVID-19) / News: Tribal and Urban Indian Organization Leader Messages on COVID-19	Indian Health Service (Principal Deputy Director Rear Adm. Michael D. Weahkee)	United States (federal); Department of Health and Human Services, Indian Health ServiceFederal	Mar. 29, 2020	2020 Q2	Emergency declarationHealth care orders	Confirmed from a secondary source
Ex. AGY-FED-HEALTH-OTHER-028	OTP Guidance for Patients Quarantined at Home with the Coronavirus (doorstep delivery protocol) (updated Mar. 30, 2020)OTP Guidance for Patients Quarantined at Home with the Coronavirus	SAMHSA, Division of Pharmacologic Therapies, Center for Substance Abuse Treatment	United States (federal); Substance Abuse and Mental Health Services AdministrationFederal	Mar. 30, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Context (guidance or announcement)Health care ordersQuarantine and isolationOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-014	DEA-DC-022 (DEA068), letter permitting DATA-waived practitioners to prescribe buprenorphine to new patients on the basis of a telephone evaluation during the COVID-19 emergencyDEA/SAMHSA Buprenorphine Telemedicine (Final)	Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA	United States (federal); Drug Enforcement Administration, Diversion Control Division (with SAMHSA)Federal	Mar. 31, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Telework mandateHealth care ordersOther	Primary source read
Ex. AGY-FED-HEALTH-OTHER-015	DEA-DC-023 (DEA075), How to Prescribe Controlled Substances to Patients During the COVID-19 Public Health Emergency (decision tree)How to Prescribe Controlled Substances to Patients During the COVID-19 Public Health Emergency	Drug Enforcement Administration, Diversion Control Division	United States (federal); Drug Enforcement Administration, Diversion Control DivisionFederal	Mar. 31, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Telework mandateHealth care ordersOther	Primary source read

Alex M. Azar II, Secretary of Health and Human Services, Declaration Under the Public Readiness and Emergency Preparedness Act for Medical Countermeasures Against COVID-19, 85 Fed. Reg. 15198 (Mar. 17, 2020) (Mar. 10, 2020) (Ex. AGY-FED-HEALTH-OTHER-040)
Centers for Disease Control and Prevention, HHS (Alex M. Azar II, Secretary), Interim Final Rule, Control of Communicable Diseases; Foreign Quarantine (requirements for airlines to collect and transmit designated passenger and crew information), 85 Fed. Reg. 7874 (Feb. 12, 2020) (Ex. AGY-FED-HEALTH-OTHER-124)
Robert R. Redfield, M.D., Director, CDC, Agency Order, Collection of Certain Data Regarding Passengers and Crew Arriving From Foreign Countries by Airlines (issued Feb. 18, 2020), 85 Fed. Reg. 10439 (Feb. 24, 2020) (Ex. AGY-FED-HEALTH-OTHER-125)
Food and Drug Administration, HHS, Policy for Diagnostics Testing in Laboratories Certified To Perform High Complexity Testing Under CLIA Prior to Emergency Use Authorization for Coronavirus Disease-2019 During the Public Health Emergency; Immediately in Effect Guidance, 85 Fed. Reg. 13138 (Mar. 6, 2020) (Feb. 29, 2020) (Ex. AGY-FED-HEALTH-OTHER-032)
Jacqueline A. O'Shaughnessy, Acting Chief Scientist, FDA (letter to CDC), Emergency Use Authorization: NIOSH-approved air purifying respirators for health care personnel (issued Mar. 2, 2020; reissued Mar. 28, 2020 and July 12, 2021) (Ex. AGY-FED-HEALTH-OTHER-052)
Department of Veterans Affairs (Secretary Robert Wilkie), VA announcement of Mar. 10, 2020: 'No Visitor' stance and suspension of new admissions at all VA nursing homes (community living centers) and spinal cord injury and disorder centers (Ex. AGY-FED-HEALTH-OTHER-064)
Federal Bureau of Prisons (Director), after coordination with DOJ and the White House, Federal Bureau of Prisons COVID-19 Action Plan, Phase Two: agency-wide modified operations (Mar. 13, 2020) (Ex. AGY-FED-HEALTH-OTHER-072)
Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA (letter to Assistant Secretary Elinore McCance-Katz, SAMHSA), DEA-DC-015, Exception to 21 C.F.R. 1301.74(h) for Narcotic Treatment Programs (take-home delivery by NTP staff, law enforcement or National Guard) (Mar. 16, 2020) (Ex. AGY-FED-HEALTH-OTHER-008)
Drug Enforcement Administration, Diversion Control Division (with the HHS Secretary's designation of Mar. 16, 2020), DEA-DC-016, COVID-19 Information Page: Telemedicine (designation that the section 802(54)(D) telemedicine allowance applies to all schedule II-V controlled substances in all areas of the United States) (Mar. 16, 2020) (Ex. AGY-FED-HEALTH-OTHER-009)
SAMHSA (Assistant Secretary for Mental Health and Substance Use), Opioid Treatment Program (OTP) Guidance (Mar. 16, 2020; updated Mar. 19, 2020): blanket take-home exceptions (Ex. AGY-FED-HEALTH-OTHER-026)
Roger T. Severino, Director, Office for Civil Rights, HHS, Notification of Enforcement Discretion for Telehealth Remote Communications During the COVID-19 Nationwide Public Health Emergency, 85 Fed. Reg. 22024 (Apr. 21, 2020) (Mar. 17, 2020) (Ex. AGY-FED-HEALTH-OTHER-001)
SAMHSA, COVID-19 Public Health Emergency Response and 42 CFR Part 2 Guidance (Mar. 19, 2020) (Ex. AGY-FED-HEALTH-OTHER-027)
Federal Bureau of Prisons, Updates to BOP COVID-19 Action Plan: Inmate Movement (Mar. 19, 2020) (Ex. AGY-FED-HEALTH-OTHER-074)
Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA, DEA-DC-017 (DEA065), Dear Registrant letter on early refills and 90-day supplies of controlled substances during the COVID-19 emergency (Mar. 20, 2020) (Ex. AGY-FED-HEALTH-OTHER-010)
Food and Drug Administration, CDRH, Guidance for Industry and FDA Staff: Enforcement Policy for Ventilators and Accessories and Other Respiratory Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (March 2020) (Mar. 22, 2020) (Ex. AGY-FED-HEALTH-OTHER-043)
Denise M. Hinton, Chief Scientist, FDA, Emergency Use Authorization: Imported, Non-NIOSH-Approved Disposable Filtering Facepiece Respirators (issued Mar. 24, 2020; reissued Mar. 28, 2020, May 7, 2020 and Mar. 24, 2021; revoked July 6, 2021) (Ex. AGY-FED-HEALTH-OTHER-049)
Denise M. Hinton, Chief Scientist, FDA, Emergency Use Authorization: Ventilators, anesthesia gas machines modified for use as ventilators, positive pressure breathing devices modified for use as ventilators, ventilator tubing connectors and ventilator accessories (Mar. 24, 2020) (Ex. AGY-FED-HEALTH-OTHER-051)
Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA, DEA-DC-018 (DEA067), Dear Registrant letter granting an exception to separate State registration for practitioners dispensing in additional States during the COVID-19 emergency (Mar. 25, 2020) (Ex. AGY-FED-HEALTH-OTHER-011)
Drug Enforcement Administration, Diversion Control Division, DEA-DC-021 (DEA073), letter to practitioner registrants and pharmacists announcing temporary exceptions for oral schedule II prescriptions in emergency situations during the COVID-19 emergency (Mar. 27, 2020) (Ex. AGY-FED-HEALTH-OTHER-013)
Department of Veterans Affairs, VA announcement of Mar. 27, 2020 releasing the VHA COVID-19 Response Plan: elective and non-emergent procedures postponed; outpatient care shifted to telehealth (Ex. AGY-FED-HEALTH-OTHER-066)
Denise M. Hinton, Chief Scientist, FDA (letter to Battelle Memorial Institute), Emergency Use Authorization: Battelle Critical Care Decontamination System for decontaminating compatible N95 respirators (issued Mar. 28, 2020; reissued Jan. 21, 2021; revoked June 30, 2021) (Ex. AGY-FED-HEALTH-OTHER-050)
Indian Health Service (Principal Deputy Director Rear Adm. Michael D. Weahkee), IHS Coronavirus (COVID-19) News page listing the Tribal and Urban Indian Organization Leader letters of Mar. 9, 16, 23 and 27, 2020 (archived Mar. 29, 2020) (Ex. AGY-FED-HEALTH-OTHER-058)
SAMHSA, Division of Pharmacologic Therapies, Center for Substance Abuse Treatment, OTP Guidance for Patients Quarantined at Home with the Coronavirus (doorstep delivery protocol) (updated Mar. 30, 2020) (Ex. AGY-FED-HEALTH-OTHER-028)
Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA, DEA-DC-022 (DEA068), letter permitting DATA-waived practitioners to prescribe buprenorphine to new patients on the basis of a telephone evaluation during the COVID-19 emergency (Mar. 31, 2020) (Ex. AGY-FED-HEALTH-OTHER-014)
Drug Enforcement Administration, Diversion Control Division, DEA-DC-023 (DEA075), How to Prescribe Controlled Substances to Patients During the COVID-19 Public Health Emergency (decision tree) (Mar. 31, 2020) (Ex. AGY-FED-HEALTH-OTHER-015)

The Orders Library

Results